Naoto Ueno
Medical Oncology · Honolulu, HINPI 1851497770
Payments from drug & device makers
Across 354 payments — averaging $24,299 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$2.9M
- Daiichi Sankyo Inc.$1.3M
- Novartis$1.1M
- Amgen$980K
- Daiichi Sankyo Company LTD$838K
- Merck Kgaa$371K
- plus $1.1M from 27 others
What the payments were for
- Consulting fees$113,04239%
- Speaking & faculty fees$12,8184%
- Travel & lodging$158,46755%
- Food & beverage$3,7201%
- Education$600%
- Gifts$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 13 | $2,929,108 |
| Daiichi Sankyo Inc. | 122 | $1,283,484 |
| Novartis | 9 | $1,125,457 |
| Amgen | 7 | $979,736 |
| Daiichi Sankyo Company LTD | 16 | $837,807 |
| Merck Kgaa | 4 | $371,184 |
| Puma Biotechnology, Inc. | 8 | $272,993 |
| Astellas Pharma Global Development | 5 | $226,955 |
| Bayer | 3 | $139,203 |
| Gilead | 15 | $91,039 |
| Chugai Pharmaceutical Co., Ltd. | 30 | $87,539 |
| Kyowa Kirin Co., Ltd | 47 | $67,777 |
| Eisai Inc. | 9 | $61,629 |
| Veru Inc. | 3 | $54,500 |
| Lilly USA, LLC | 5 | $26,158 |
| Sysmex America, Inc. | 19 | $9,590 |
| Sumitomo Pharma Co., Ltd. | 7 | $8,601 |
| AstraZeneca | 7 | $5,811 |
| Pfizer | 5 | $5,351 |
| Eisai CO., LTD. | 1 | $3,594 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $2,160 |
| Takeda Pharmaceutical Company, Limited | 1 | $2,160 |
| Immunomedics, Inc. | 1 | $2,100 |
| E.r. Squibb & Sons, L.L.C. | 2 | $1,985 |
| Genentech USA, Inc. | 2 | $1,899 |
| Taiho Oncology, Inc. | 3 | $1,684 |
| Telix Pharmaceuticals | 1 | $1,500 |
| Caris MPI, Inc. | 2 | $313 |
| Janssen Scientific Affairs, LLC | 1 | $145 |
| Astrazeneca UK Limited | 1 | $135 |
| Novocure Inc. | 1 | $54 |
| Genentech, Inc. | 2 | $45 |
| Accord Healthcare, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Enhertu$23,428
- Non-Covered Product$16,789
- TECENTRIQ$11,573
- Curebest 95GC$8,783
- Trodelvy$7,053
- LENVIMA$3,594
- XGEVA$3,300
- ILLUCCIX$3,000
- Itovebi$1,875
- Vitrakvi$1,199
- Truqap$820
- 95GC Breast$360
- MI CANCER SEEK$233
- KISQALI$230
- Erleada$145
- AKEEGA$145
- XTANDI$124
- ORGOVYX$124
- TALZENNA$124
How this compares
Too few medical oncology providers in Hawaiito place this figure against a meaningful peer group, so we don't.
Other medical oncology in Honolulu
- Jami FukuiHonolulu$667K
- Shaun DoneganHonolulu$17K
- Clayton ChanHonolulu$2K
- Clayton ChongHonolulu$2K
- Charles MillerHonolulu$326
- Reuben GuerreroHonolulu$35
- Kevin LohHonolulu$31
- Kitty VictoriaKealakekua$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.